1800 202 8726
Nausea prevention

Aprepitant (Aprecap, Emend) — The Medicine for Delayed Nausea

Aprepitant is the medicine in your pack that targets nausea starting the day after chemotherapy. It works differently from ondansetron — targeting a different pathway — which is exactly why both are prescribed together.

Medically reviewed by Dr. Naresh Gundu, Medical Oncologist, MBBS (Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar) · DNB Internal Medicine (Sir Gangaram Hospital, New Delhi) · DM Medical Oncology (AIIMS) · Last reviewed September 2026

  • Not a cancer treatment — Aprepitant does not treat your cancer. It prevents delayed nausea so your body can tolerate the treatment that does.
  • Targets delayed nausea — Nausea that begins the day after chemotherapy is driven by a different pathway than same-day nausea. Aprepitant targets that pathway.
  • Part of a combination — It works alongside ondansetron and dexamethasone, not instead of them — the combination NCCN, ASCO and ESMO recommend for high-risk regimens.
  • For specific regimens only — Not every patient needs it. Your oncologist included it because your chemotherapy falls into the highly emetogenic category.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Reviewed by a senior medical oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Aprepitant (sold in India as Aprecap, also known as Emend) prevents nausea and vomiting that begins the day after chemotherapy and can last for several days. It targets a pathway — the NK1 receptor — that ondansetron does not reach. NCCN, ASCO and ESMO recommend it for highly emetogenic regimens.

What is aprepitant and why is it in my medicine pack?

Aprepitant — sold in India as Aprecap and internationally as Emend — is an NK1 receptor antagonist. It blocks a chemical called substance P, which is the main driver of nausea and vomiting in the days after chemotherapy, not the hours.

Your other anti-nausea medicine, such as ondansetron, targets a different pathway — one that controls acute nausea on treatment day. Aprepitant fills the gap that ondansetron cannot reach. That is why both are prescribed together.

It does not treat your cancer. It is there so that delayed nausea does not become severe enough to stop you eating, drinking, or completing your treatment.

Which chemotherapy regimens typically include aprepitant?

  • Cisplatin-containing chemotherapy, which is classified as highly emetogenic across cancer types
  • AC chemotherapy (anthracycline plus cyclophosphamide), the standard backbone for many breast cancer regimens
  • Other highly emetogenic combinations that NCCN, ASCO and ESMO classify as requiring NK1 receptor antagonist cover
  • Some moderately emetogenic regimens where your oncologist judges the nausea risk to be high enough
  • If you are unsure why your regimen includes it, ask your oncologist or pharmacist at your next visit

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

Why is aprepitant given over several days and not just once?

Chemotherapy-induced nausea has two distinct phases. The acute phase peaks in the first hours after treatment and is mainly driven by serotonin. The delayed phase begins the following day and can continue for several days — driven by substance P, not serotonin.

Ondansetron works on the acute phase. Aprepitant is designed for the delayed phase. The multi-day course is timed to maintain protective levels during the window when delayed nausea is most likely to peak.

Do not stop taking it early because you feel well — feeling well may mean it is working. Call your team the same day if you miss a dose or are unsure whether to take the next one.

Did you know?

Before NK1 receptor antagonists like aprepitant became available, delayed nausea — not same-day nausea — was the side effect most likely to lead patients to delay or decline a subsequent chemotherapy cycle.

ASCO and ESMO antiemetic guidelines now classify NK1 receptor antagonists as a required element of the antiemetic regimen for highly emetogenic chemotherapy.

Source: ASCO Clinical Practice Guideline Update: Antiemetics in Oncology

Explore 74 more Chemotherapy and Supportive Medicines by Name topics

Chemotherapy Drugs by Name

Drug Interactions, TB & Chronic Medicines

HUB — Chemotherapy Drugs by Name

HUB — Generic, Branded and Biosimilar Chemotherapy in India

HUB — Supportive Medicines Used With Chemotherapy

All Chemotherapy and Supportive Medicines by Name →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Is aprepitant a chemotherapy drug?

No. Aprepitant is a supportive medicine — it does not target or treat your cancer in any way. Its only purpose is to prevent the delayed nausea and vomiting that certain chemotherapy regimens cause. Many people find it in their pack without a clear explanation of what it is for. It is there to protect your quality of life and your ability to continue treatment, not to add to your cancer therapy.

I already have ondansetron. Why do I need aprepitant as well?

Because they target completely different pathways. Ondansetron blocks serotonin receptors and works mainly in the first hours after chemotherapy. Aprepitant blocks NK1 receptors and works mainly in the days that follow. Neither covers the other's window. The combination of both — alongside dexamethasone in most regimens — is what NCCN, ASCO and ESMO recommend for highly emetogenic chemotherapy, because no single medicine covers both phases.

Why does my regimen include aprepitant but a friend on chemotherapy does not have it?

Not every chemotherapy regimen carries the same nausea risk. Aprepitant is specifically recommended for highly emetogenic regimens — those where severe nausea would be expected in a large proportion of patients without antiemetics. If your friend is on a different regimen, or one with a lower emetogenic classification, the guidelines may not require it. The decision is based on the specific medicines in your regimen, not on your cancer type.

Can I skip aprepitant on a day I feel fine?

No — aprepitant is preventive, not something you take after nausea starts. It needs to be taken on the schedule your oncologist and pharmacist set, even when you feel well, because feeling well may be a sign that it is working. If you have missed a dose or are unsure whether to take the next one, call your treating team the same day rather than deciding on your own.

Does aprepitant interact with other medicines?

Yes, and this matters. Aprepitant is known to interact with several medicines including some steroids, blood thinners, and other drugs processed by the liver. Your oncologist chose your antiemetic regimen with those interactions already in mind. Before each cycle, tell your team about every medicine you are taking — prescription, over the counter, herbal, and Ayurvedic — so interactions can be checked and managed.

What side effects should I tell my team about while taking aprepitant?

Tell your team about any new symptom, including hiccups that do not settle, unusual fatigue, or digestive changes. Because aprepitant is taken alongside several other medicines, it can be hard to know which is causing what — and that is exactly why your team needs to hear about any new symptom rather than you attributing it to chemotherapy alone and waiting.

My pack says Aprecap, not Emend. Is this the same medicine?

Yes. Aprecap is a brand of aprepitant manufactured for the Indian market. Emend is the same active molecule under a different brand name used internationally. Both contain aprepitant. If your prescription says either brand name or the generic name aprepitant, you are being given the same medicine. If you have any doubt about what is in your pack, show it to your oncologist or pharmacist.

What should I do if I vomit shortly after taking an aprepitant tablet?

Call your treating team or the CION helpline the same day. Do not take an additional tablet on your own judgment — whether to repeat a dose is a clinical decision that depends on timing and what else you have taken. Your team will advise you on that day and whether anything needs to be adjusted before your next cycle.

Full index

Browse all 579 chemotherapy topics

Every page in this section, grouped by the part of treatment it belongs to. Open a group to see what is in it.

Before You Start: Tests, Ports & Fertility42
Blood Counts, Infection, Fever & Emergencies73

Anaemia & Low Haemoglobin

HUB — Low Blood Counts, Infection and Fever During Chemotherapy

Chemotherapy and Supportive Medicines by Name75

Chemotherapy Drugs by Name

HUB — Chemotherapy Drugs by Name

HUB — Generic, Branded and Biosimilar Chemotherapy in India

HUB — Supportive Medicines Used With Chemotherapy

Chemotherapy at CION Cancer Clinics1
Chemotherapy by Cancer Type and Special Situations5

Special Populations & Comorbidities

HUB — Chemotherapy in Special Situations

Chemotherapy in Hyderabad: Cost, Centres & Access93

HUB — Choosing a Chemotherapy Centre and Safe Administration

Common Side Effects and How They Are Managed78
Food, Diet, Hydration & Household Safety6
How Chemotherapy Is Given: Regimens, Cycles & Infusion Days85

Other Ways Chemotherapy Is Given

HUB — Cycles, Schedules and What Happens on Infusion Day

Is It Working, Finishing Chemotherapy & Survivorship7

Is It Working? Response & Scans

HUB — Is Chemotherapy Working? Scans and Response

HUB — When Chemotherapy Stops Working

Nerve, Skin, Heart, Kidney and Cognitive Effects5

Skin, Nails & Hand-Foot Syndrome

Heart, Lung & Organ Toxicity

HUB — Effects on the Heart, Kidneys, Liver and Nerves

Understanding Chemotherapy, Myths & Trials97

HUB — Chemotherapy Myths and Alternative Treatment Claims

HUB — Clinical Trials in Cancer Treatment

HUB — What Is Chemotherapy and Why Has It Been Advised?

Work, Family, Relationships and Emotional Support12
Call now Book free consultation